SMSMED — Scandinavian Medical Solutions A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK110.75m
- DKK159.33m
- DKK226.68m
- 62
- 49
- 17
- 34
Annual cashflow statement for Scandinavian Medical Solutions A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | DAS | DAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.96 | 10.9 | 14.7 | 16.6 | 13.8 |
| Depreciation | |||||
| Non-Cash Items | -0.146 | -0.333 | -0.022 | -0.575 | -3.68 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.54 | -6.54 | -25.9 | -28.9 | -13.9 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9.38 | 4.02 | -10.6 | -8.37 | 3.39 |
| Capital Expenditures | — | — | -13.8 | -40.8 | -18.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.029 | -0.269 | -0.011 | 0.954 | 7.34 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.029 | -0.269 | -13.8 | -39.9 | -11.1 |
| Financing Cash Flow Items | -2.77 | -8.39 | -3.3 | -0.025 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.77 | 11.1 | 26.7 | 21.2 | 18.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.58 | 14.8 | 2.36 | -27.3 | 10.3 |